GB2117766B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB2117766B
GB2117766B GB08308053A GB8308053A GB2117766B GB 2117766 B GB2117766 B GB 2117766B GB 08308053 A GB08308053 A GB 08308053A GB 8308053 A GB8308053 A GB 8308053A GB 2117766 B GB2117766 B GB 2117766B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08308053A
Other versions
GB8308053D0 (en
GB2117766A (en
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Priority to GB08308053A priority Critical patent/GB2117766B/en
Publication of GB8308053D0 publication Critical patent/GB8308053D0/en
Publication of GB2117766A publication Critical patent/GB2117766A/en
Application granted granted Critical
Publication of GB2117766B publication Critical patent/GB2117766B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
GB08308053A 1982-03-24 1983-03-24 Pharmaceutical compositions Expired GB2117766B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08308053A GB2117766B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8208608 1982-03-24
GB8230148 1982-10-22
GB08308053A GB2117766B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
GB8308053D0 GB8308053D0 (en) 1983-05-05
GB2117766A GB2117766A (en) 1983-10-19
GB2117766B true GB2117766B (en) 1985-08-29

Family

ID=27261527

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08308053A Expired GB2117766B (en) 1982-03-24 1983-03-24 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB2117766B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
DK174238B1 (en) * 1984-10-30 2002-10-07 Otsuka Pharma Co Ltd 5-Fluorouracil derivatives, their preparation and drugs containing such compounds
GB9002061D0 (en) * 1990-01-30 1990-03-28 Bannister Joseph V Iron assay
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
WO2012142087A1 (en) * 2011-04-12 2012-10-18 The Procter & Gamble Company Metal bleach catalysts

Also Published As

Publication number Publication date
GB8308053D0 (en) 1983-05-05
GB2117766A (en) 1983-10-19

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
HK16090A (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8423800D0 (en) Pharmaceutical compositions
CY1678A (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
ZA833781B (en) Pharmaceutical compositions
GB8308055D0 (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
GB2114001B (en) Nasel pharmaceutical compositions
GB8305028D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8332653D0 (en) Pharmaceutical composition
GB8331068D0 (en) Pharmaceutical compositions
GB8329391D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
7732 Case decided by the comptroller ** patent revoked (sect. 73(2)/1977)